Назальную вакцину от COVID-19 ждут в Татарстане весной

“The nasal vaccine is an additional protection, barrier protection for the respiratory tract,” said the Minister of HEALTH of the Republic of Tatarstan Marat Sadykov.

According to him, the region has more than 600,000 doses of the COVID-19 vaccine . Of these, 80% are Sputnik V, about 8,000 doses of CoviVac and EpiVacCorona are also available, but in small quantities. The minister explained that the latest vaccine is less in demand among the population.

The nasal vaccine is the second component of Sputnik V, sprayed into the nose. This type of vaccine against COVID-19 has no side effects, said earlier the DIRECTOR of the center. Gamalei Alexander Gintsburg. On November 24, Russian President Vladimir Putin was revaccinated with the drug .

According to RBC, the nasal vaccine has not passed all clinical trials. They will last until December 2023 and will be attended by 500 volunteers.

In Tatarstan, more than 2.07 million people have been vaccinated against CORONAVIRUS today.